ACS chemical neuroscience molecule spotlight on potiga (Ezogabine)

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

On June 10th, 2011, the U.S. Food and Drug Administration approved Potiga (ezogabine) as an add-on medication for the treatment of seizures in adults, and it is being developed by Valeant Pharmaceuticals.

Original languageEnglish (US)
Pages (from-to)632
Number of pages1
JournalACS Chemical Neuroscience
Volume3
Issue number8
DOIs
StatePublished - Aug 15 2012

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Fingerprint Dive into the research topics of 'ACS chemical neuroscience molecule spotlight on potiga (Ezogabine)'. Together they form a unique fingerprint.

  • Cite this